Literature DB >> 21929329

Update on the chemopreventive effects of ginger and its phytochemicals.

Manjeshwar Shrinath Baliga1, Raghavendra Haniadka, Manisha Maria Pereira, Jason Jerome D'Souza, Princy Louis Pallaty, Harshith P Bhat, Sandhya Popuri.   

Abstract

The rhizomes of Zingiber officinale Roscoe (Zingiberaceae), commonly known as ginger, is one of the most widely used spice and condiment. It is also an integral part of many traditional medicines and has been extensively used in Chinese, Ayurvedic, Tibb-Unani, Srilankan, Arabic, and African traditional medicines, since antiquity, for many unrelated human ailments including common colds, fever, sore throats, vomiting, motion sickness, gastrointestinal complications, indigestion, constipation, arthritis, rheumatism, sprains, muscular aches, pains, cramps, hypertension, dementia, fever, infectious diseases, and helminthiasis. The putative active compounds are nonvolatile pungent principles, namely gingerols, shogaols, paradols, and zingerone. These compounds are some of the extensively studied phytochemicals and account for the antioxidant, anti-inflammatory, antiemetic, and gastroprotective activities. A number of preclinical investigations with a wide variety of assay systems and carcinogens have shown that ginger and its compounds possess chemopreventive and antineoplastic effects. A number of mechanisms have been observed to be involved in the chemopreventive effects of ginger. The cancer preventive activities of ginger are supposed to be mainly due to free radical scavenging, antioxidant pathways, alteration of gene expressions, and induction of apoptosis, all of which contribute towards decrease in tumor initiation, promotion, and progression. This review provides concise information from preclinical studies with both cell culture models and relevant animal studies by focusing on the mechanisms responsible for the chemopreventive action. The conclusion describes directions for future research to establish its activity and utility as a human cancer preventive and therapeutic drug. The above-mentioned mechanisms of ginger seem to be promising for cancer prevention; however, further clinical studies are warranted to assess the efficacy and safety of ginger.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21929329     DOI: 10.1080/10408391003698669

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  46 in total

1.  Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer.

Authors:  Suzanna M Zick; D Kim Turgeon; Jianwei Ren; Mack T Ruffin; Benjamin D Wright; Ananda Sen; Zora Djuric; Dean E Brenner
Journal:  Mol Carcinog       Date:  2014-04-24       Impact factor: 4.784

2.  The Role of 6-Gingerol on Inhibiting Amyloid β Protein-Induced Apoptosis in PC12 Cells.

Authors:  Gao-feng Zeng; Shao-hui Zong; Zhi-yong Zhang; Song-wen Fu; Ke-ke Li; Ye Fang; Li Lu; De-Qiang Xiao
Journal:  Rejuvenation Res       Date:  2015-08-20       Impact factor: 4.663

3.  Differential control of growth, apoptotic activity and gene expression in human colon cancer cells by extracts derived from medicinal herbs, Rhazya stricta and Zingiber officinale and their combination.

Authors:  Ayman I Elkady; Rania Abd El Hamid Hussein; Osama A Abu-Zinadah
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Genetic diversity and structure of Brazilian ginger germplasm (Zingiber officinale) revealed by AFLP markers.

Authors:  Eleonora Zambrano Blanco; Miklos Maximiliano Bajay; Marcos Vinícius Bohrer Monteiro Siqueira; Maria Imaculada Zucchi; José Baldin Pinheiro
Journal:  Genetica       Date:  2016-10-08       Impact factor: 1.082

Review 5.  The effects of phytochemicals and herbal bio-active compounds on tumour necrosis factor-α in overweight and obese individuals: a clinical review.

Authors:  Mohammad Bagherniya; Atena Mahdavi; Elahe Abbasi; Milad Iranshahy; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Inflammopharmacology       Date:  2022-01-08       Impact factor: 4.473

6.  Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract.

Authors:  Sushma R Gundala; Rao Mukkavilli; Chunhua Yang; Pooja Yadav; Vibha Tandon; Subrahmanyam Vangala; Satya Prakash; Ritu Aneja
Journal:  Carcinogenesis       Date:  2014-01-15       Impact factor: 4.944

7.  Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation.

Authors:  Meera Brahmbhatt; Sushma R Gundala; Ghazia Asif; Shahab A Shamsi; Ritu Aneja
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

Review 8.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 9.  Metabolism and breast cancer risk: frontiers in research and practice.

Authors:  Ruth E Patterson; Cheryl L Rock; Jacqueline Kerr; Loki Natarajan; Simon J Marshall; Bilge Pakiz; Lisa A Cadmus-Bertram
Journal:  J Acad Nutr Diet       Date:  2012-11-03       Impact factor: 4.910

10.  Metabolites of ginger component [6]-shogaol remain bioactive in cancer cells and have low toxicity in normal cells: chemical synthesis and biological evaluation.

Authors:  Yingdong Zhu; Renaud F Warin; Dominique N Soroka; Huadong Chen; Shengmin Sang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.